ATE202354T1 - Tetracyclische kondensierte heterocyclische verbindungen zur behandlung von seniler demenz - Google Patents

Tetracyclische kondensierte heterocyclische verbindungen zur behandlung von seniler demenz

Info

Publication number
ATE202354T1
ATE202354T1 AT94118734T AT94118734T ATE202354T1 AT E202354 T1 ATE202354 T1 AT E202354T1 AT 94118734 T AT94118734 T AT 94118734T AT 94118734 T AT94118734 T AT 94118734T AT E202354 T1 ATE202354 T1 AT E202354T1
Authority
AT
Austria
Prior art keywords
senile dementia
heterocyclic compounds
condensed heterocyclic
substituted
treating senile
Prior art date
Application number
AT94118734T
Other languages
English (en)
Inventor
Giichi Goto
Yuji Ishihara
Masaomi Miyamoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE202354T1 publication Critical patent/ATE202354T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT94118734T 1993-11-30 1994-11-29 Tetracyclische kondensierte heterocyclische verbindungen zur behandlung von seniler demenz ATE202354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29979993 1993-11-30
JP5598494 1994-03-25

Publications (1)

Publication Number Publication Date
ATE202354T1 true ATE202354T1 (de) 2001-07-15

Family

ID=26396889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94118734T ATE202354T1 (de) 1993-11-30 1994-11-29 Tetracyclische kondensierte heterocyclische verbindungen zur behandlung von seniler demenz

Country Status (5)

Country Link
US (2) US5620973A (de)
EP (1) EP0655451B1 (de)
AT (1) ATE202354T1 (de)
CA (1) CA2136913A1 (de)
DE (1) DE69427517T2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658909A (en) * 1994-11-17 1997-08-19 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
US6534496B1 (en) 1997-04-17 2003-03-18 Takeda Chemical Industries, Inc. Thermogenic composition and benzazepine thermogenics
HUP0104493A3 (en) 1998-09-30 2002-12-28 Takeda Pharmaceutical Drugs for improving vesical excretory strength
CA2375851A1 (en) * 1999-06-14 2000-12-21 Neurogen Corporation 1-azatricyclic-4-benzylpiperazines
US6881842B2 (en) 2000-09-21 2005-04-19 Takeda Chemical Industries, Ltd. Process for producing tricyclic fused heterocyclic derivative
CA2471760A1 (en) 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Preventives/remedies for urinary disturbance
WO2005049622A1 (ja) * 2003-11-19 2005-06-02 Japan Tobacco Inc. 5-5員縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての用途
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
RU2387655C2 (ru) * 2004-08-09 2010-04-27 Бристол-Маерс Сквибб Компани Ингибиторы репликации вируса гепатита с
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US9193728B2 (en) 2010-02-18 2015-11-24 Medivation Technologies, Inc. Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
US9040519B2 (en) 2010-02-18 2015-05-26 Medivation Technologies, Inc. Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
US9034865B2 (en) 2010-02-18 2015-05-19 Medivation Technologies, Inc. Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
WO2012112965A1 (en) 2011-02-18 2012-08-23 Medivation Technologies, Inc. Compounds and methods of treating diabetes
WO2022221415A2 (en) 2021-04-13 2022-10-20 The Regents Of The University Of California Tetracyclic compounds for treating brain disorders
WO2025080608A1 (en) * 2023-10-09 2025-04-17 The Regents Of The University Of California Desamide isotryptamine tetracycles for treating brain disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403156A (en) * 1966-06-07 1968-09-24 American Home Prod N-acyl substituted polycylclic isoquinolines
US4192874A (en) * 1978-11-02 1980-03-11 American Hoechst Corporation Substituted 1,2,6,7-tetrahydroindolo[1,7-ab][1,5]benzodiazepines
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
FI913588A0 (fi) * 1989-11-27 1991-07-26 Vni Khim Farmatsevtichesky I I 2,3,3a,4,5,6-hexahydro-8-cyclohexyl-1h -pyrazino-(3,2,1-j,k)-karbazolhydroklrid, foerfarande foer dess framstaellning och daerpao baserat antidepressivt farmaceutiskt preparat.
TW197442B (de) * 1990-02-08 1993-01-01 Pfizer
JPH0413626A (ja) * 1990-05-01 1992-01-17 Q P Corp 健脳組成物
TW197435B (de) * 1990-11-22 1993-01-01 Takeda Pharm Industry Co Ltd
TW263504B (de) * 1991-10-03 1995-11-21 Pfizer
SE9103752D0 (sv) * 1991-12-18 1991-12-18 Astra Ab New compounds
TW218875B (de) * 1992-03-09 1994-01-11 Takeda Pharm Industry Co Ltd
CA2092112A1 (en) * 1992-03-23 1993-09-24 Nobuyoshi Iwata Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use
TW248556B (de) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co

Also Published As

Publication number Publication date
US5620973A (en) 1997-04-15
EP0655451B1 (de) 2001-06-20
EP0655451A1 (de) 1995-05-31
CA2136913A1 (en) 1995-05-31
DE69427517T2 (de) 2002-05-29
DE69427517D1 (de) 2001-07-26
US5814642A (en) 1998-09-29

Similar Documents

Publication Publication Date Title
DE69427517D1 (de) Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
DE69433148D1 (de) Tricyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
CA2335285A1 (en) Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
NO983099L (no) Nye retrovirale proteasehemmere
DK0655996T3 (da) Substituerede benzylamino-nitrogenholdige, ikke-aromatiske, heterocykliske forbindelser
HU9600963D0 (en) Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
DE69227571D1 (de) Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren
FI982436A0 (fi) Kondensoituneet heterosykliset yhdisteet
DE68929059D1 (de) N-Acylpyrrolidine, Verfahren zur Herstellung und ihre Verwendung zur Prevention und/oder Behandlung von Amnesie
ES2132284T3 (es) Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
DE69225601D1 (de) Azabicycloarylacetylen- und arylenynoxine als cholinergische mittel und verfahren zur behandlung
EP0567090A3 (de)
AU1041497A (en) Epoxysuccinamide derivative or salt thereof and medicine comprising the same
EP0921122A4 (de) Neue epoxysuccinamid-derivate oder ihre salze
NZ501896A (en) Process for producing isoxazolidinedione compound
FI935799A0 (fi) Arylsubstituerade heterocykliska foereningar
ATE237611T1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
DE69329184D1 (de) Alkylsubstituierte heterocyclische Verbindungen
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
FI904449A0 (fi) N-azasicyklo/3.3.0/oktanamider av aromatiska syror.
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
NO984547L (no) Nye oksazolidinderivater, fremgangsmÕte for deres fremstilling, samt legemidler inneholdende disse forbindelser
DE69808607D1 (de) Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz
TH26143A (th) "ลิ้นปิดเปิดที่ใช้กับขวดก๊าซ"

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties